InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（2 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Reilly Thomas Charles, 首席财务官. Officer active across 2 companies, notably Cara Therapeutics, Inc.. Aggregated, 11 reports have been logged. Split: 0 buy · 2 sells. Total volume traded: €45k. History available since 24 August 2021. The latest transaction was filed on 3 March 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Reilly Thomas Charles
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报11 总计
16,667 股Ordinary SharesSEC:0000950170-24-079717:0
33,333 股Ordinary SharesSEC:0000950170-24-076300:0
44,933 股Ordinary SharesSEC:0000950170-24-010534:0
51,500 股Ordinary SharesSEC:0000950170-24-004305:0
16,667 股Ordinary SharesSEC:0000899243-23-016904:0
33,334 股Ordinary SharesSEC:0000899243-23-016257:0
2,044 股@ US$11.3846.7% 占其流量Common StockSEC:0001209191-22-016438:0
20,000 股0Common StockSEC:0001209191-22-013992:0
11,170 股0Common StockSEC:0001209191-21-070801:0
1,982 股@ US$14.2053.3% 占其流量Common StockSEC:0001209191-21-054303:0
5,334 股0Common StockSEC:0001209191-21-053538:0
11 条申报中的 11 条
About Reilly Thomas Charles
Reilly Thomas Charles is Directeur Financier and has filed 11 filings in total. In the recent filings available, they cover the period from 2021-08-26 to 2024-07-01, with EUR 44790 of sales and no purchases. The companies listed are Amarin CORP Plc\uk, where he is EVP and CFO, and Cara Therapeutics, Inc., where he is Chief Financial Officer.
